B. 1. Leem, Bioproduction 2008 : Etat des lieux et recommandations pour l''attractivité de la France [en ligne], Disponible sur, 2008.

S. Latieule, La 13e fusion [en ligne] Disponible sur, p.38665, 2011.

. Leem, Marché mondial : L'économie du Médicament [en ligne]. 2013. Disponible sur

B. Kelley, Industrialization of mAb production technology: The bioprocessing industry at a crossroads, mAbs, vol.1, issue.5, pp.443-452, 2009.
DOI : 10.4161/mabs.1.5.9448

. Takween, Production de protéines recombinantes [en ligne] Disponible sur : http://www.takween.com/biotechnologies/proteines-recombinantes

T. Munro, S. Mahler, and E. Huang, Bridging the gap Facilities and technologies for development of early stage therapeutic mAb candidates. mAbs, pp.440-452, 2011.

M. Pinet, Utilisation des anticorps monoclonaux dans la prévention et le traitement de maladies infectieuses

C. Janeway, K. Murphy, W. M. Immunobiologie, M. Robertson, and R. Locksley, Immunité: la réponse immunitaire dans les maladies infectieuses et inflammatoires, Mars, p.162, 2009.

S. Siberil, C. Dutertre, and C. Boix, Anticorps monoclonaux ?? usage th??rapeutique??: un peu d'histoire, beaucoup d'ing??nierie, et ??? quelques succ??s cliniques, Transfusion Clinique et Biologique, vol.12, issue.2, pp.114-122, 2005.
DOI : 10.1016/j.tracli.2005.04.016

F. Li, N. Vijayasankaran, and . Shen, Cell culture processes for monoclonal antibody production. mAbs, pp.466-477, 2010.

M. Pohlscheidt and R. Kiss, Recent Advances and Trends in the Biotechnology Industry - Development and manufacturing of Recombinant Proteins and Antibodies, American Pharmaceutical Review, 2013.

P. Chames, D. Baty, and . Mai, Ingénierie des anticorps monoclonaux, Biofutur, vol.288, pp.43-46, 2008.

J. Mccafferty, A. Griffiths, G. Winter, and D. Chiswell, Phage antibodies: filamentous phage displaying antibody variable domains, Nature, vol.348, issue.6301, 1990.
DOI : 10.1038/348552a0

A. Frenzel, M. Hust, S. Faye, L. Landry, N. Lerouge et al., Expression of recombinant antibodies La production de protéines à usage biopharmaceutique dans les plantes, Frontiers in Immunology Médecine/sciences, vol.4, issue.16, pp.867-877, 2001.

L. Houdebine, Antibody manufacture in transgenic animals and comparisons with other systems, Current Opinion in Biotechnology, vol.13, issue.6, pp.625-629, 2002.
DOI : 10.1016/S0958-1669(02)00362-2

F. Wurm, Production of recombinant protein therapeutics in cultivated mammalian cells, Nature Biotechnology, vol.57, issue.11, pp.1393-1398, 2004.
DOI : 10.1038/nbt1021

J. Kim, Y. Kim, and G. Lee, CHO cells in biotechnology for production of recombinant proteins: current state and further potential, Applied Microbiology and Biotechnology, vol.153, issue.3, p.2012
DOI : 10.1007/s00253-011-3758-5

X. Xu, H. Nagarajan, and N. Lewis, The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line, Nature Biotechnology, vol.62, issue.8, pp.29-735, 2011.
DOI : 10.1093/glycob/cwp079

J. Zhang, Mammalian Cell Culture for Biopharmaceutical Production, Manual of Industrial Microbiology and Biotechnology, 2010.
DOI : 10.1128/9781555816827.ch12

J. Ryan, Guide général de cryoconservation de cultures de cellules animales, 2013.

J. Birch and A. Racher, Antibody production, Advanced Drug Delivery Reviews, vol.58, issue.5-6, pp.671-685, 2006.
DOI : 10.1016/j.addr.2005.12.006

R. Costa, E. Rodrigues, and M. Henriques, Guidelines to cell engineering for monoclonal antibody production, European Journal of Pharmaceutics and Biopharmaceutics, vol.74, issue.2, 2010.
DOI : 10.1016/j.ejpb.2009.10.002

F. Valk, J. Brunner, D. , D. Smet, and K. , Optimization of chemically defined cell culture media, Toxicology in Vitro, vol.74, issue.24 4, pp.127-138, 2010.

F. Wurm, Production of recombinant protein therapeutics in cultivated mammalian cells, Nature Biotechnology, vol.57, issue.11, pp.1393-1398, 2004.
DOI : 10.1038/nbt1021

T. Munro, S. Mahler, and E. Huang, Bridging the gap, mAbs, vol.13, issue.5, pp.440-452, 2011.
DOI : 10.1016/j.jchromb.2006.11.018

S. Primos, Principes de génie génétique, Octobre, 2004.

T. Lai, Y. Yang, K. Ng, and S. , Advances in Mammalian Cell Line Development Technologies for Recombinant Protein Production, Pharmaceuticals, vol.6, issue.5, pp.579-603, 2013.
DOI : 10.3390/ph6050579

V. Lamy, Etude des propriétés anti-cancéreuses des Lupulones, micro constituants spécifiques du houblon: aspects cellulaires et physiopathologiques, Th. D : Sciences du Vivant, 2009.

J. Heron, Y. Cancérologie-générale-meng, J. Liang, W. Wong, and V. Chisholm, Disponible sur : http://www.oncoprof.net/Generale2000/g04_Diagnostic/Histologie/Technique- image/dg_histo_tech_43 Green fluorescent protein as a second selectable marker for selection of high producing clones from transfected CHO cells, Gene, vol.33, pp.242-201, 2000.

S. Dharshanan, H. Chong, and C. Hung, Rapid automated selection of mammalian cell line secreting high level of humanized monoclonal antibody using Clone Pix FL system and the correlation between exterior median intensity and antibody productivity, Electronic Journal of Biotechnology, vol.14, issue.2, 2011.
DOI : 10.2225/vol14-issue2-fulltext-7

G. Richardson, N. Lin, and K. Lacy, Cell Xpress??? Technology Facilitates High-Producing Chinese Hamster Ovary Cell Line Generation Using Glutamine Synthetase Gene Expression System, In Cells and Culture, vol.4, pp.45-48, 2010.
DOI : 10.1007/978-90-481-3419-9_9

. Th, D : Pharmacie, 2008.

G. Kretzmer, Industrial processes with animal cells, Applied Microbiology and Biotechnology, vol.59, pp.135-142, 2002.

M. Dardenne, M. Cherlet, and J. Engasser, Kinetic studies of fed-batch hybridoma cult ures : effect of various feeding compositions and flow rates Product s for today, prospects for tomorrow, Animal Cell Technology, pp.542-544, 1994.

T. Fletcher, Designing Culture Media for Recombinant Protein Production, BioProcess International, 2005.

A. Reddys, Small scale cell culture performance of recombinant Chinese Hamster Ovary cells

D. Jayme, T. Watanabe, and T. Shimada, Basal medium development for serum-free culture: a historical perspective, Cytotechnology, vol.23, issue.1/3, pp.95-101, 1997.
DOI : 10.1023/A:1007967602484

J. Zanghi, W. Renner, J. Bailey, and M. Fussenegger, The Growth Factor Inhibitor Suramin Reduces Apoptosis and Cell Aggregation in Protein-Free CHO Cell Batch Cultures, Biotechnology Progress, vol.16, issue.3, pp.319-344, 2000.
DOI : 10.1021/bp0000353

J. Ryan, Produire de grandes quantités de cellules : guide de scale-up des cultures cellulaires en faible volume -1ère partie. 45: Figuet D. Les bioréacteurs jetables Vallez-Chetreanu F. Caracterization of the mechanism of action of spin-filters for animal cell perfusion cultures, Th. D : Chimie et génie chimique N. Small-Scale Monoclonal Antibody Production, 2004.

M. Camus, E. Deguine, R. D. Heidemann, R. Lütkemeyer, D. Büntemeyer et al., 50: AnHydre. Le HandBook de l'oxygène dissous Un guide pratique pour les mesures d'oxygène dissous. YSI Handbook Oxygène Dissous 51: Celld. Equipements de production, d'analyse et de contrôle pour les Biotechnologies [en ligne] Disponible sur : http://celld.com/flashmenu/fogale-biomasse-evo-200 PID utilisé en régulation de position et/ou de vitesse de moteurs électriques [en ligne], Chinese hamster ovary cells. Cytotechnology Disponible sur Effects of dissolved oxygen levels and the role of extra-and intracellular amino acid concentrations upon the metabolism of mammalian cell lines during batch and continuous cultures, pp.215-220, 1998.

N. Barbouche, Réponse biologique de cellules animales a des contraintes hydrodynamiques : simulation numérique, expérimentation et modélisation en bioréacteurs de laboratoire, Th. D : Procédés Biotechnologiques et Alimentaires : Institut polytechnique de Lorraine Li Z et al. Scale-Up Analysis for a CHO Cell Culture Process, 2008.

F. Schmidt, Optimization and scale up of industrial fermentation processes, Applied Microbiology and Biotechnology, vol.24, issue.4, pp.425-435, 2005.
DOI : 10.1007/s00253-005-0003-0

G. Chua, Process optimization and scale-up for the production of a diagnostic monoclonal antibody against congenital adrenal hyperplasia (CAH). Th, p.2010

H. Liu, J. Ma, and C. Winter, Recovery and purification process development for monoclonal antibody production, 60: ANSM. Partie II des Bonnes Pratiques de Fabrication, [en ligne]. p37, pp.480-499, 2010.
DOI : 10.1046/j.1423-0410.2003.00285.x

. Disponible-sur, sante.fr/var/ansm_site/storage/original/application/bbf377b519b5a07b63b8b2ba8f 7c2b35.pdf 61 : Nawfel M